semaglutide litigation Plaintiffs' lawyers chosen to lead Ozempic SpicyIP Tidbit] Patent's Gone, War's

Researchers examined data from more than 100,000 individuals with diabetes and found that users of GLP-1 receptor agonists, including Ozempic, may face a higher risk of developing NAION compared to those using other diabetes medications

received an honorarium from Eli Lilly to deliver a talk at the 2025 BOMSS scientific meeting

Regular monitoring and open communication with your medical team will help mitigate these risks

Our master nurse injectors at InjectCo will assess your health history and weight loss goals to determine a suitable treatment plan and semaglutide dosage for you, so you can achieve your target weight within a healthy timeline